Protalex Inc (PRTX.PK) Quote| Reuters.com
Edition:
United States

Protalex Inc (PRTX.PK)

PRTX.PK on OTC Markets Group

3.00USD
24 Jun 2016
Change (% chg)

-- (--)
Prev Close
$3.00
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
2,379
52-wk High
$5.84
52-wk Low
$2.30

PRTX.PK

Chart for PRTX.PK

About

Protalex, Inc. is a development-stage biopharmaceutical company. The Company is focused on the development of a class of biopharmaceutical drugs for treating autoimmune and inflammatory diseases including rheumatoid arthritis (RA). The Company’s lead product, PRTX-100, is a formulation of staphylococcal protein A, an immunomodul... (more)

Overall

Beta: 0.25
Market Cap(Mil.): $86.30
Shares Outstanding(Mil.): 28.77
Dividend: --
Yield (%): --

Financials

  PRTX.PK Industry Sector
P/E (TTM): -- 33.67 34.69
EPS (TTM): -0.32 -- --
ROI: -- 14.91 14.13
ROE: -- 15.99 15.35

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider : MacroRisk Analytics/EconomicInvestor
$25.00
Provider : ValuEngine, Inc.
$25.00
Provider : Pechala's Reports
$25.00
Provider : Reuters Investment Profile
$20.00
Provider : GlobalData
$300.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.